Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02898220 · ClinicalTrials.gov registry record
Trans-MAPP II Study of Urologic Chronic Pelvin Pain
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 72
- Enrollment target
NCT02898220: Completed study, sponsored by University of Pennsylvania.
NCT02898220 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 72 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02898220 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 72 participants
- Enrollment target
Study Summary
The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to focus on a broader approach to the study of Interstitial Cystitis (IC)/ Bladder Pain Syndrome (BPS) in men and women, and Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) in men, than previously undertaken. Patients with IC or CP are being recruited for a new study called the "Trans-MAPP Study of Urologic Chronic Pelvic Pain: Symptom Patterns Study (SPS). This research study will recruit Control Participants to better understand the symptoms of individuals with some form of IC or CP. As with many chronic pain disorders, IC and CP are poorly understood, and treatment is often not helpful. The goal of this study is to better understand how pain is felt in people with IC or CP and the investigators hope that this study will lead to improvement in the treatment of IC and CP.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2016-09 |
| Est. Completion | 2022-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02898220
The ClinicalTrials.gov registry entry for NCT02898220 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02898220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02898220 about?
NCT02898220 is a clinical study titled "Trans-MAPP II Study of Urologic Chronic Pelvin Pain". The Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network has been established by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) to focus on a broader approach to the study of Interstitial Cysti...
What is the current status of trial NCT02898220?
This trial is currently completed. The enrollment target is 72 participants. The study started on 2016-09. Estimated completion is 2022-06.
Who is sponsoring clinical trial NCT02898220?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.